Education and Training
Understanding How Ketamine Brings About Rapid Improvement in OCD
The purpose of this study is to understand how ketamine brings about rapid improvement in Obsessive-Compulsive Disorder (OCD) symptoms.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: Ketamine
- drug: Midazolam
Eligibility
Inclusion Criteria for participants with OCD:
- age 18-65
- Primary diagnosis of OCD
- Sufficient severity of OCD symptoms
- ability to tolerate a treatment-free period
- capacity to provide informed consent
Inclusion criteria for healthy controls:
- ages 18-65
- capacity to provide informed consent
Exclusion criteria for participants with OCD:
- Psychiatric or medical conditions that make participation unsafe
- pregnant or nursing females
- concurrent use of any medications that might increase the risk of participation (e.g.
drug interactions)
- presence of metallic device or dental braces
Exclusion criteria for healthy controls:
- any current or lifetime psychiatric diagnosis
- pregnant or nursing females
- major medical or neurological problem
- presence of metallic device or dental braces
Ages Eligible for Study
18 Years - 65 Years
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Elizabeth McCarthy
650-723-4095
Not Recruiting